The competition for the European Medicines Agency is not a horse race but the first concrete, effective decision the EU has to make in the wake of Brexit - and one with long-lasting consequences. A responsible yet ambitious mindset is therefore in order, writes Sandro Gozi.
Whether it is an elderly German man who lost his job or a young boy that reached Europe fleeing war at home, Europe’s excluded are falling through the cracks of healthcare systems, writes Médecins du Monde.
Cosmetic products are not only skin deep. They bring real benefits to people’s lives and contribute massively to Europe's economy. It is time to recognise their broader contribution, argues John Chave.
The considerable problems posed by the illicit trade in tobacco products are widely recognised, yet agreeing on how to provide an effective solution is still the subject of deliberation and delays, writes Nicola Sudan.
The links between climate change and public health are staggering. By implementing clean air policies, governments can save lives and cut health costs while mitigating climate change, writes Génon Jensen.
The debate on hormone disruptors in the EU is more political than scientific. A decision to ignore the question of potency would cause needless disruption to regulators, industries and consumers, writes Christopher Borgert.
Every year on World Tuberculosis (TB) Day, the World remembers those who have died and the millions that suffer every year from of an infection that is both preventable and curable, write a group of health experts.
The use of heavy fuel oil by shipping in the Arctic could have disastrous consequences. Banning this fuel would protect the region’s rich wildlife, improve human health and benefit the climate, writes Sue Libenson.
Despite the encouraging and historic climate agreement at COP 21 in Paris, politicians all over the world argue that quick climate action is too costly. But if they redid the calculation and included co-benefits they would take action now. And they should, argues Christian Friis Bach.